Influence of preanalytical sampling conditions on the 1H NMR metabolic profile of human blood plasma and introduction of the Standard PREanalytical Code used in biobanking

Variations in sample collection, processing and storage within the field of clinical metabolomics might hamper its effective implementation. In this study, the impact of relevant preanalytical conditions on the plasma 1H NMR metabolic profile was examined. The biobanking community recently developed a method for coding preanalytical conditions called the Standard PREanalytical Code (SPREC). It is envisaged that SPREC will ultimately identify which samples are fit for a particular analysis, based on prior validation by a panel of experts in the respective field. In an effort to validate SPREC for 1H NMR plasma metabolomics, we have coded the conditions used here, when possible, according to SPREC and evaluated its power to identify preanalytical conditions that affect the plasma 1H NMR metabolic profile. From all preanalytical conditions studied, only prolonged processing delays (3 and 8 h) have a significant impact on the plasma 1H NMR metabolic profile as compared to the reference condition (30 min). Principal component analysis shows a clear systematic shift as a function of increasing processing delay. Nevertheless, the inter-individual variation is clearly much larger than this preanalytical variation, indicating that the impact on multivariate group classification will be minimal. Nonetheless, we recommend to keep the time gap between blood collection and centrifugation similar for all samples within a study. The implementation of SPREC within clinical metabolomics allows for an appropriate sample encoding and exclusion of samples that were subjected to unwanted, interfering preanalytical conditions. Without doubt, it will contribute to the validation of 1H NMR metabolomics in clinical, biobank and multicenter research settings.

[1]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[2]  Song Liu,et al.  Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. , 2013, Translational oncology.

[3]  Phenotyping human blood plasma by 1H-NMR: a robust protocol based on metabolite spiking and its evaluation in breast cancer , 2015, Metabolomics.

[4]  Elaine Holmes,et al.  Impact of analytical bias in metabonomic studies of human blood serum and plasma. , 2006, Analytical chemistry.

[5]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[6]  A. Atay,et al.  Effects of hemolysis interferences on routine biochemistry parameters. , 2011, Biochemia medica.

[7]  C. Kennedy,et al.  A comparison of hemolysis rates using intravenous catheters versus venipuncture tubes for obtaining blood samples. , 1996, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[8]  Joana Pinto,et al.  Human plasma stability during handling and storage: impact on NMR metabolomics. , 2014, The Analyst.

[9]  Zeper Abliz,et al.  Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on reliability of potential biomarkers. , 2013, Analytical chemistry.

[10]  N. Yoshikawa,et al.  Hemolysis in Serum Samples Drawn by Emergency Department Personnel versus Laboratory Phlebotomists , 2002 .

[11]  Irena Spasic,et al.  A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. , 2008, International journal of epidemiology.

[12]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[13]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.

[14]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[15]  Sebastiano Collino,et al.  Clinical metabolomics paves the way towards future healthcare strategies. , 2013, British journal of clinical pharmacology.

[16]  P J Sadler,et al.  High resolution 1H n.m.r. studies of vertebrate blood and plasma. , 1983, The Biochemical journal.

[17]  Alexandros Makriyannis,et al.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters , 2008, Clinical chemistry and laboratory medicine.

[18]  T. Veenstra,et al.  Analytical and statistical approaches to metabolomics research. , 2009, Journal of separation science.

[19]  O. Fiehn Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[20]  F. Betsou,et al.  Standard Preanalytical Coding for Biospecimens: Defining the Sample PREanalytical Code , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[21]  Umberto Nanni,et al.  Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). , 2012, Biopreservation and biobanking.

[22]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[23]  J. Baynes,et al.  Medical biochemistry [4th ed.] , 2014 .

[24]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  Brian C Sweatman,et al.  Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. , 2002, Journal of pharmaceutical and biomedical analysis.

[26]  D. Yücel,et al.  Effect of in vitro hemolysis on 25 common biochemical tests. , 1992, Clinical chemistry.

[27]  T. Lundstedt,et al.  Diagnostic properties of metabolic perturbations in rheumatoid arthritis , 2011, Arthritis Research & Therapy.

[28]  J. Lindon,et al.  Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. , 2008, Annual review of analytical chemistry.

[29]  Jildau Bouwman,et al.  Evaluation of field-desorption and fast atom-bombardment mass spectrometric profiles by pattern recognition techniques , 1983 .

[30]  G. Lippi,et al.  Influence of hemolysis on routine clinical chemistry testing , 2006, Clinical chemistry and laboratory medicine.

[31]  Fotini Betsou,et al.  Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks , 2011, Journal of biomolecular NMR.

[32]  Bernhard Brutscher,et al.  Recent advances in solution NMR: fast methods and heteronuclear direct detection. , 2009, Chemphyschem : a European journal of chemical physics and physical chemistry.

[33]  J. Gardeniers,et al.  High-resolution liquid- and solid-state nuclear magnetic resonance of nanoliter sample volumes using microcoil detectors. , 2008, The Journal of chemical physics.

[34]  A. Zhang,et al.  Power of metabolomics in biomarker discovery and mining mechanisms of obesity , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.